WTA: Unseeded Karolina Muchova returns to U.S. Open semifinals

Date:

Share post:


Unseeded Karolina Muchova advanced to her second consecutive U.S. Open semifinal, defeating No. 22 seed Beatriz Haddad Maia of Brazil 6-1, 6-4 in New York.

The Czech needed just one hour, 25 minutes in the win.

In the semifinal, Muchova will meet the winner of the Wednesday’s later match between No. 1 Iga Swiatek of Poland and No. 6 Jessica Pegula. And she will hope for top health. In the second set against Haddad Maia, Muchova took multiple breaks for unspecified medical treatment and bathroom visits.

“A little weird match, I have to say,” Muchova said in her on-court interview. “I had a lot of problems, I wouldn’t like to comment on it. I’m happy I managed it.”

After the 2023 semifinals, she underwent wrist surgery and didn’t return to play until June.

Muchova, 28, moved to 4-0 in her career against the Brazilian. She has one appearance in a Grand Slam final, losing to Swiatek at the French Open in three sets in 2023.

Muchova, who ousted four-time major champion Naomi Osaka of Japan and No. 5 seed Jasmine Paolini of Italy in earlier rounds, has yet to drop a set in the tournament.

She won the first five games of Wednesday’s quarterfinal.

–Field Level Media

spot_img

Related articles

WTA: WTA roundup: Elena Rybakina rolls into Strasbourg quarters

Fourth-seeded Elena Rybakina of Kazakhstan cruised into the quarterfinals with a 6-1, 6-3 win Tuesday over China's Xinyu...

WTA: WTA roundup: Emma Raducanu stuns Daria Kasatkina at Strasbourg

Great Britain's Emma Raducanu defeated sixth-seeded Daria Kasatkina of Australia 6-1, 6-3 on Monday to advance to the...

ATP: ATP roundup: One-sided matches in rainy Geneva

No. 6 seed Hubert Hurkacz of Poland hit 17 winners and saved 3 of 4 break points in...

ATP: Novak Djokovic confirms coaching plans for Geneva, French Open

Novak Djokovic has appointed long-time friend and former doubles partner Dusan Vemic as his coach for both this...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.